The best prospect to halt the pandemic Covid-19which you can’t really expect that she will go off alone, as had been the Sars outbreak of 2003, will have a preventive treatment.
Despite the rhetoric on the need to consider the future vaccines against the Covid-19 as “common goods of humanity “, each secures its future supply and making bets. Thus, on Saturday, the France, Germany, the netherlands and Italy have entered into an agreement with the pharmaceutical group, the anglo-Swedish AstraZeneca, which guarantees the supply of 300 million doses for the european Union.
AstraZeneca is one of the ten firms that have already launched clinical trials in humans, one of five selected in early June by the program Warp Speed (speed of lightning) in the united states. She hopes, “if all goes well “ , be ready in the fall. But there is no guarantee that their vaccine will be effective. The “if all goes well “common to the ads and hopes of a vaccine from this year (as the american Moderna), is a wish more than a promise.
“A contradiction “
“There is a contradiction, tip Patrick Zylberman, a historian of health and author of The war of the vaccines (Odile Jacob). If a vaccine is achieved very quickly without all the usual tests, you are exposing yourself to manage more of vaccine-related injuries serious. It is really a very delicate problem, including for the governments that will buy it. “
Rapid access to a vaccine as soon as it will be at the point is a political issue as much as health. Today, Emmanuel Macron visits the site of production of vaccines of Sanofi in Marcy-l’etoile (Rhône). In may, the boss of the French multinational had announced that it would provide priority to the Americans, before being denied by the president of Sanofi France.
On Wednesday, the President will meet with representatives of the main private laboratories in the race (135 projects in the world) to discuss global access, fair remuneration, allocation of capacity, production…
For Patrick Zylberman,it is the national egoism which will continue to predominate : “After the 2003 Sars, it was a question that the EU negotiates directly and manages the inventory of vaccines. It never arrived. “
– .
